Fortaleza Asset Management’s SYNAGEVA BIOPHARMA CORP COM STK (DE) GEVA Stock Holding History

Fortaleza Asset Management’s Portfolio GEVA Stock Details GEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-1,935	Closed	-$189K	–	234
2015 Q1	$189K	Sell	1,935 -3,000	-61%	-$318K	0.11%	145
2014 Q4	$458K	Sell	4,935 -435	-8%	-$34.3K	0.21%	144
2014 Q3	$369K	Sell	5,370 -70	-1%	-$5.01K	0.17%	160
2014 Q2	$570K	Buy	5,440 +1,100	+25%	+$93.6K	0.26%	152
2014 Q1	$360K	Buy	+4,340	New	+$401K	0.18%	160

Fortaleza Asset Management's GEVA Position: Q2 2015 in Review

Fortaleza Asset Management sold out of SYNAGEVA BIOPHARMA CORP COM STK (DE) (GEVA) in Q2 2015, closing a stake of 1,935 shares — an estimated $189K sold.

Fortaleza Asset Management first reported a position in GEVA in Q1 2014 and held it in 5 quarters. The position peaked at $570K in Q2 2014. 0 funds tracked by Wall St. Rank hold GEVA as of Q2 2015.

Fortaleza Asset Management reported no remaining SYNAGEVA BIOPHARMA CORP COM STK (DE) position as of Q2 2015 after selling out during the quarter.
Fortaleza Asset Management sold 1,935 SYNAGEVA BIOPHARMA CORP COM STK (DE) shares in Q2 2015, an estimated $189K.
Fortaleza Asset Management first reported a position in SYNAGEVA BIOPHARMA CORP COM STK (DE) in Q1 2014 and held it in 5 quarters.
Fortaleza Asset Management's SYNAGEVA BIOPHARMA CORP COM STK (DE) position peaked at $570K in Q2 2014.
0 funds tracked by Wall St. Rank held SYNAGEVA BIOPHARMA CORP COM STK (DE) as of Q2 2015.

Based on Fortaleza Asset Management's 13F filing for Q2 2015, filed 28 Jul 2015.